The PWHL is Just Getting Started With Hilary Knight
Original Report
In this episode of The Deal, Hilary details for Jason and Alex the process of starting a league where players were partners from the jump and why Mark Walter and Billie Jean King were the right...
In this episode of The Deal, Hilary details for Jason and Alex the process of starting a league where players were partners from the jump and why Mark Walter and Billie Jean King were the right people to work with. She also explains how the momentum from this year’s Olympics bled into the PWHL season and why Heated Rivalry is one of the best things to ever happen to hockey. Finally, she shares her hopes for her post-playing career (spoiler alert! she wants to own a team) and the responsibility of being the face of her sport. (Source: Bloomberg)
Glass House Analysis
Energy prices affect virtually every aspect of daily life—from commuting costs to heating bills to the price of groceries (which must be transported). For working families, energy represents one of the most volatile and impactful line items in their budgets. Energy policy decisions ripple through the economy, affecting everything from manufacturing competitiveness to household financial stress.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Land Reclamation!
“Buy land,” they said, “they aren’t making any more.” But in fact, we used to make a lot of land. Half the land area of Boston, a quarter of Manhattan, and 15% of San Francisco were raised from the...
What AI companies want for the millions they're spending on elections
Lawmakers are working on AI legislation — and two major industry PACs are each pushing for their own version of regulation.
AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse
A late-stage clinical trial failed to miss its primary endpoint, U.K.'s laregst drugmaker said Thursday.
Schwab strategists warn of a major market shift: The era of easy index gains is officially over.
More geopolitical instability, more frequent supply shocks and macro volatility are facing investors in an era that’s just starting, says Charles Schwab.